From ‘Accelerate’ To ‘Confirm’: US FDA Launches Transparency Program On Cancer Drug Approvals

 
• By Sue Sutter

Oncology Center of Excellence’s Project Confirm, formerly known as Project Accelerate, is intended to promote transparency of outcomes related to cancer drug accelerated approvals; initiative includes searchable databases on the status of oncology/hematology indications.

Confirm
FDA's oncology center is emphasizing the "confirm" part of the accelerated approval pathway in a new transparency project. • Source: Alamy

More from Review Pathways

More from Pathways & Standards